Welcome to Genescient

Genescient is a new biology company that combines genomics with massive selective screening to analyze, penetrate and exploit whole genomes in order to develop novel therapeutics. Genescient's research focuses on the development of therapeutic substances that target the chronic diseases of aging. For more information on Genescient's scientific approach please refer to this Science Primer.

Genescient's first product will be available for human testing early in the 2nd Quarter of 2009.

News & Publications

* 03.13.09	Convergence: Longevity Panel: Gregory Benford, Board Chairman, Genescient, participates in Longevity Panel at Convergence 08.
* 03.04.09	Genescient and Kronos Announce Alzheimer's Disease Collaboration: Genescient Corporation and Kronos Science Laboratory will work together to analyze the Kronos Alzheimer's Case-Control Database, considered to be the finest Alzheimer's Disease genetic data set in the US.
* 02.16.09	Quest for the fountain of youth: Longevity is knocking on our doors
* 01.01.09	Genescient Co-founder and Chairman Gregory Benford answers the Edge question What Will Change Everything?

Upcoming Testing

If you wish to participate in our upcoming substance testing, please write to us at:

info at genescient dot com

Note from the Webmaster: As with any good startup, we chose to focus our resources on getting a product out. We have achieved outstanding results in the lab and our first product is almost ready for human testing.

We have received your requests for additional information and will be posting more soon as we revamp this simple site.

Thank you for your interest.